Back to Top

Ask about this Application

Application

Benchling for Antibody R&D

Benchling

Aug 24, 2021

Abstract

Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates continue to push the envelope of antibody efficacy and safety. But the industry requires a new kind of digital solution that can offer a holistic view of antibody research and development, integrating large and disparate data sets to extract timely insights, while providing complete traceability to sequences, cell lines, and production processes. Learn how Benchling improves antibody R&D productivity and increases collaboration by 95%.

Application File

Benchling for Antibody R&D.pdf

Comments

Be the first to comment.

Submit a Comment

First Name *

Last Name *

Email *

Comments *

Premier Sponsor
Benchling